Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dexmedetomidine and Fentanyl-Propofol Sedation on Peri- and Postprocedural Outcomes in Renal Sympathetic Denervation: A Single-Center Retrospective Study

NCT07293273 is registered in ClinicalTrials.gov with Ebru Girgin Dinc as lead sponsor.

NCT NCT07293273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07293273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dexmedetomidine and Fentanyl-Propofol Sedation on Peri- and Postprocedural Outcomes in Renal Sympathetic Denervation: A Single-Center Retrospective Study
Lead sponsor
Ebru Girgin Dinc
Phase
Observational
Overall status
Completed
Start date
December 30, 2024
Completion date
August 1, 2025
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conscious sedation, dexmedetomidine, hypertension, resistant, procedural sedation and analgesia, sympathectomy